Publication | Open Access

A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group Study

NanomedicinePhase Ii EvaluationMedicinePersistent Platinum-resistant OvarianPharmacologyGynecologyFallopian TubeTumor TargetingCancer TreatmentOncologyGynecology OncologyOvarian Cancer